• Publications
  • Influence
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
TLDR
Prevalence rates of different physical illnesses as well as important individual lifestyle choices, side effects of psychotropic treatment and disparities in health care access, utilization and provision that contribute to these poor physical health outcomes are reported.
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
TLDR
Weight gain and changes in lipid and metabolic parameters in patients without prior antipsychotic medication exposure are studied and mean levels increased significantly for total cholesterol, triglycerides, and non-high-density lipoprotein cholesterol.
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis
TLDR
The data suggest that the risk for MetS is similarly elevated in the diagnostic subgroups of severe mental illness, and routine screening and multidisciplinary management of medical and behavioral conditions is needed in these patients.
The schizophrenia prodrome revisited: a neurodevelopmental perspective.
TLDR
It is concluded that a neurodevelopmental model of schizophrenia is supported by the data and that a range of novel treatment strategies may be neuroprotective by directly affecting the disorder's vulnerability core.
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
TLDR
The metabolic and cardiovascular risks of various antipsychotic medications in adults and children are outlined, the disparities in health care are defined, and recommendations for screening and monitoring of patients taking these agents are made.
National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.
TLDR
On a population basis, adults make considerably more medical visits with a prescription of antipsychotics than do adolescents or children, and recently antipsychotic treatment has increased especially rapidly among young people.
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
TLDR
Results from 11 long-term studies support the idea that second- generation antipsychotics have a reduced risk for tardive dyskinesia, compared to first-generation antipsychotic, although the doses of haloperidol used in the comparator studies were relatively high.
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
TLDR
The adoption of the recommendations presented in this paper across health care systems throughout the world will contribute to a significant improvement in the medical and related psychiatric health outcomes of patients with SMI.
Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents.
  • C. Correll, H. Carlson
  • Medicine, Psychology
    Journal of the American Academy of Child and…
  • 1 July 2006
TLDR
Clinicians and caregivers need to be aware of potential endocrine and metabolic adverse effects of psychiatric medications, and a careful selection of patients, choice of agents with potentially lesser risk for these adverse events, healthy lifestyle counseling, as well as close health monitoring are warranted.
...
...